Atlas Trials

Study to Assess Safety and Activity of Combination Therapy of VRC07-523LS and Vorinostat on HIV-infected Persons

Clinical trial NCT03803605 · COMPLETED

Trial details

NCT number
NCT03803605
Sponsor
University of North Carolina, Chapel Hill
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
HIV-1 Infection
Start date
2019-02-12
Primary completion
2021-01-28
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.